Modified new drug R&D is key for drug industry to survive.

Director Yeo Jae-cheon of Korea Drug Research Association stressed to say under the title of "Today and tomorrow of our R&D for modified new drugs" in the Spring symposium of the Korea Society of Pharmaceutical Science on May 11 that the local drug industry should not look aside the importance of the modified new drug R&D in order to solidify the industry as a nation's economic driving engine a...